WHO declares Hepatitis D virus as "carcinogenic": What does this mean amidst rising liver diseases
The World Health Organization (WHO) and the International Agency for Research on Cancer (IARC) have classified the hepatitis D virus (HDV) as carcinogenic to humans. HDV has joined hepatitis B and C on the list of cancer-causing agents.
On Monday, during the occasion of World Hepatitis Day, July 28, 2025, WHO urged governments and partners to accelerate efforts to eliminate viral hepatitis as a public health threat and reduce liver cancer deaths. Hepatitis (B, C, and, D) affects over 300 million people globally and claims 1.3 million lives each year, mainly from liver cirrhosis and cancer.
"Every 30 seconds, someone dies from a hepatitis-related severe liver disease or liver cancer.
Yet we have the tools to stop hepatitis,' Dr Tedros Adhanom Ghebreyesus, WHO Director-General, said in a statement.
Viral hepatitis (types A, B, C, D, and E), is the major cause of acute liver infection. Hepatitis B, C, and D can result in chronic infections that increase the risk of liver cirrhosis, liver failure, or liver cancer. Yet most people with hepatitis don't know they're infected.
What is Hepatitis D
Hepatitis D, also known as delta hepatitis, is a rare but severe liver infection caused by the Hepatitis D virus.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Moose Approaches Girl At Bus Stop In Chittagong - Watch What Happens
Happy in Shape
Undo
It is rare because it can only infect people who are already infected with the hepatitis B virus (HBV). HDV can only occur as a co-infection or superinfection in people who are HBV-positive.
Hepatitis D is carcinogenic
The International Agency for Research on Cancer (IARC) has recently classified hepatitis D as
carcinogenic
to humans. Compared to HBV alone, HDV has a two- to six-fold higher risk of liver cancer, making it a serious infection. By classifying HDV as carcinogenic, the health organizations are hoping to raise awareness, improve screening, and expand access to new treatments for hepatitis D across the globe.
'WHO has published guidelines on testing and diagnosis of Hepatitis B and D in 2024, and is actively following the clinical outcomes from innovative treatments for hepatitis D,' Dr Meg Doherty, incoming Director of Science for Health at WHO, said.
What is the treatment for HDV?
Oral medication can treat Hepatitis C within 2 to 3 months, while effectively controlling hepatitis B with lifelong treatment. The treatment options for HDV, on the other hand, are still developing.
Major progress in preventing liver cirrhosis and cancer deaths depends on further steps in managing the global burden such as vaccination, testing, harm reduction, and treatment.
In a 2024
report
, the WHO had said that India had over 3.5 crore cases of viral hepatitis, including 2.98 crore hepatitis B cases, in 2022, which accounts for 11.6% of the total disease burden globally that year.
7 Ways to check for fatty liver at home
Liver diseases are on the rise globally, and HDV being classified as carcinogenic has raised concerns. It adds to the urgency to address this growing crisis, as co-infections exacerbate liver damage and cancer risk. Regular screening and early detection of co-infections, including HDV, will be crucial in reducing the global burden of viral hepatitis
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
7 hours ago
- Hans India
Breastfeeding Week (1 to 7 August): Celebrating nature's first superfood
Breastfeeding is one of the most natural and powerful ways to nourish a newborn. Far beyond being just a means of sustenance, breast milk plays a crucial role in shaping an infant's health, development, and immunity. Packed with essential nutrients and living antibodies, it adapts to a baby's changing needs, offering unparalleled protection in the earliest stages of life. As science continues to uncover the remarkable benefits of breastfeeding, it becomes even clearer why this 'liquid gold' is considered the gold standard of infant nutrition Every year, from August 1st to 7th, the world observes Breastfeeding Week to raise awareness about the importance of breast milk for infants, mothers, and society at large. Organized by the World Alliance for Breastfeeding Action (WABA) and endorsed by the World Health Organization (WHO) and UNICEF, this week serves as a powerful reminder that breastfeeding is not just a personal act—it's a public health imperative. Why Breast Milk Matters Breast milk is more than just food; it's a living, dynamic source of nutrition uniquely tailored for each baby. It contains the perfect balance of proteins, fats, carbohydrates, vitamins, and antibodies that help an infant grow and build immunity. In fact, the first milk produced after childbirth, called colostrum, is often termed 'liquid gold' for its high concentration of protective antibodies and nutrients. 'Breast milk is nature's first vaccine—it not only provides optimal nutrition but also boosts the baby's immune system from day one,' says Dr. Swathi Gogineni, Consultant – Obstetrics & Gynecology, Infertility Specialist & Laparoscopic Surgeon, Apollo Cradle and Children's Hospital, Jubilee Hills, Hyderabad. According to the WHO, exclusive breastfeeding for the first six months of life reduces infant mortality and provides critical protection against diseases such as pneumonia, diarrhea, and even obesity later in life. After six months, continued breastfeeding along with appropriate complementary foods can protect and nourish the child well into the toddler years. Benefits for Babies • Stronger Immunity: Breast milk is packed with antibodies that help babies fight off viruses and bacteria. • Brain Development: Essential fatty acids in breast milk contribute to cognitive development and visual acuity. • Lower Risk of SIDS: Studies show a reduced risk of sudden infant death syndrome in breastfed babies. • Bonding: The act of breastfeeding promotes skin-to-skin contact and emotional bonding between mother and child. Benefits for Mothers • Faster Recovery: Breastfeeding helps the uterus return to its normal size and reduces postpartum bleeding. • Calorie Burn: It naturally helps in burning extra calories, aiding in postpartum weight loss. • Reduced Risk of Diseases: Women who breastfeed have a lower risk of breast and ovarian cancers, Type 2 diabetes, and postpartum depression. • Emotional Connection: It nurtures a deep, hormonal bonding experience that supports maternal mental health. Challenges and the Need for Support While the benefits of breastfeeding are well-documented, not every mother finds it easy. Pain, latching difficulties, lack of information, societal stigma, and returning to work can all be barriers. This is where awareness, education, and support systems are vital. Workplaces need to adopt mother-friendly policies—such as maternity leave, breastfeeding breaks, and hygienic nursing rooms. Hospitals and healthcare providers should promote the Baby-Friendly Hospital Initiative (BFHI) to encourage early initiation and exclusive breastfeeding. Families and communities play a central role, too. Encouraging words, helping hands, and emotional support can make a huge difference in a mother's confidence and commitment to breastfeeding. Spreading the Message This Breastfeeding Awareness Week, let us: • Educate new mothers about the science and benefits of breast milk. • Support lactating mothers at home, in workplaces, and in public spaces. • Normalize breastfeeding through positive messaging in media and community events. • Advocate for policy changes that create breastfeeding-friendly environments. Final Thoughts Breast milk is a natural, sustainable, and cost-effective way to nourish and protect infants. It's the first vaccine, the first food, and the first bond. By spreading awareness and supporting mothers in their breastfeeding journey, we contribute to a healthier generation and a more compassionate society.
Hans India
8 hours ago
- Hans India
Health experts urge govt to mandate dengue reporting
Hyderabad: Health experts are urging the government to establish a mechanism that ensures hospitals report dengue complications. They also suggest that protocol-based treatment should be encouraged through knowledge-sharing between tertiary centres and rural areas to prevent deaths and huge expenditures. As dengue is a seasonal, epidemic disease, complications often require tertiary centre monitoring. From prevention to updating protocol-based treatment, a new approach is urgently needed for this tropical disease. Dr Madap Karuna, a consultant at EMRI Green Health Services, said that since dengue is a tropical disease, the cases may not be the same in Western countries, and therefore they may not have case studies of severe cases. 'There is a WHO protocol where we get to know not much about severe dengue management. The protocols have not been updated for severe cases,' said Dr Karuna. 'The policymakers also should know that the medical field is evolving; there are new diseases. During COVID, everybody was doing research and they gave a lot of options. Now, dengue is also changing patterns, as there are severe complications. Multi-centric studies should be encouraged by policymakers. We should give our data to WHO so that every doctor should know how to tackle it.' The issue doctors face with dengue cases is that patients are often brought to the hospital in a bad state. Doctors said that in this scenario, if there is already a publication or knowledge-sharing of experiences, the feedback can be helpful for patient treatment. The private sector has been making some effort through conferences at a nominal price, but there is no such mechanism from the rural centres, doctors noted. Doctors point out a rise in the number of dengue cases until September-October and therefore want the government to initiate awareness campaigns. Dr Karuna said that dengue has existed for two decades and people should know when to refer a patient, what type of treatment can be provided, etc. Similarly, the cost of treatments is also pushing patients into poverty. 'Once a child is in hospital, it is very difficult to manage,' said Dr Karuna. Senior cardiologist and faculty at the International Training Center at Gandhi Medical College, Dr Vijay Rao, said that while protocols and guidelines do exist in every field of medicine, sometimes it is practical common sense that helps in clinical medicine, especially in developing countries where resources are scarce.
The Print
9 hours ago
- The Print
All about hepatitis D, deadly viral hepatitis given a ‘cancer' tag by WHO
Hepatitis D or HDV, which only affects individuals infected with hepatitis B, is associated with a two- to six-fold higher risk of liver cancer compared to hepatitis B alone, according to the IARC. Viral hepatitis, characterised by inflammation of the liver, can be caused by the five known hepatitis viruses—A, B, C, D and E. Among these, only hepatitis B, C, and D can lead to chronic infections that significantly increase the risk of cirrhosis, liver failure, or liver cancer. New Delhi: The World Health Organisation-International Agency for Research in Cancer (WHO-IARC) has now declared hepatitis D, a little-known but deadly viral hepatitis, as carcinogenic, expressing hope that this will lead to more screening and access to new treatments. It is estimated that globally, 48 million people are affected with HDV, which in combination with the hepatitis B virus, has the highest fatality rate of all the hepatitis infections, at 20 percent. Its prevalence is highest in low- and middle-income regions in Africa and Asia, apart from the Amazon basin and India. Scientific evidence has shown that 8-37 percent, depending on the region, of those infected with hepatitis B, also have HDV. A 2024 report by the WHO had said that India had over 3.5 crore cases of viral hepatitis—including 2.98 crore hepatitis B cases—in 2022, accounting for 11.6 percent of the total disease burden globally that year. Over 1.25 lakh people, the report suggested, had died due to hepatitis B and C in India that year. Senior gastroenterologists and public health professionals suggested that HDV is largely undetected in the country, mainly because of lack of screening, and is more prevalent in some parts of east India and among people infected with HBV. 'From a public health perspective, this classification by WHO-IARC highlights the importance of incorporating HDV awareness, screening, and prevention into the existing hepatitis B prevention programme,' Dr Saswata Chatterjee, gastroenterologist with the Calcutta Medical Research Institute (CMRI), told ThePrint. With liver cancer becoming a challenging burden, screening and early detection of co-infections, such as HDV, will be crucial in reducing chronic complications of viral hepatitis, he added. Also Read: Govt says no plan to ban heartburn drug ranitidine, carcinogenic impurities within safe limits HBV triggers rapid progression to end-stage liver failure Dr Piyush Ranjan, senior gastroenterologist with Sir Ganga Ram Hospital in Delhi, explained that HDV is a satellite virus that requires hepatitis B virus (HBV) for replication, causing the most aggressive form of viral hepatitis. Compared to hepatitis B and C, HDV leads to more rapid progression to cirrhosis and liver cancer. In clinical terms, explained CMRI's Dr Chatterjee, HDV occurs as a co-infection—when it is contracted simultaneously with HBV—or a superinfection—when an individual who is chronically infected with HBV becomes infected with HDV. While HBV increases the risk of developing liver complications, HDV increases this risk substantially, accelerating the progression of liver fibrosis, cirrhosis and malignancy. The mode of transmission of this hepatitis virus is similar to hepatitis B and C—through contaminated injections, mother to child, and sexual contact. Dr Vibhor Sharma, a medical oncologist with Asian Hospital, highlighted that co-dependency of HDV on HBV leads to making hepatitis worse in patients. 'HDV-triggered liver disease is more severe as it can result in end-stage liver failure in less than ten years,' he said, adding that as compared to the general population in India, this form of hepatitis is seen more commonly in intravenous drug users, HIV/AIDS patients and those with chronic HBV. The declaration by the WHO-IARC is crucial, said the medical oncologist as HDV, despite its aggressiveness in triggering liver cancers, is mostly undiagnosed and is grossly underreported in developing countries such as India. Prevention and management Clinicians say HDV is preventable at a low cost, through immunisation. The effective methods to prevent both HBV and HDV are the vaccines against hepatitis B, safe blood practices, sterilisation of medical equipment, and safe sex practices, said Dr Chatterjee. The HBV vaccine in India, as part of the Union government 's Universal Immunization Programme, was piloted in 2002-03 and then scaled up in the entire country in 2010 to protect children from the acute infection. It is now provided as part of the pentavalent vaccine at 6, 10 & 14 weeks apart from the birth dose of hepatitis B vaccine. However, a 2020 study from India said that although the coverage of third-dose hepatitis B vaccine has reached 86 percent in the country, the birth dose coverage was under 50 percent in 2015 despite high rates of institutional deliveries. The WHO says that while treatment with oral medicine can cure hepatitis C within 2 to 3 months and effectively suppress hepatitis B with life-long therapy, treatment options for hepatitis D are evolving. Sir Ganga Ram's Dr Ranjan maintained that for those already infected, management is challenging, with limited approved therapies, though newer agents like bulevirtide—an antiviral therapy especially developed against the condition—offer promise. 'The carcinogen tag will hopefully intensify global surveillance, funding, and research to curb the burden of HDV-associated liver cancer,' said the gastroenterologist. (Edited by Gitanjali Das) Also Read: Cancer warning on liquor bottles 'long overdue'. Even 'light', 'moderate' drinking poses threat
